Similar articles

• [Apheresis of low-density lipids in the treatment of hereditary hypercholesterolemia].

  Konovalov GA, Kukharchuk VV, Sinitsin VV, Trakht IN, Adamova IIu. Konovalov GA, et al. Vutr Boles. 1989;28(4):133-6. Vutr Boles. 1989. PMID: 2596087 Bulgarian. No abstract available.
• LDL-apheresis with the HELP system: a 16-month study in severe hypercholesterolemic patients with ischemic heart disease.

  Baggio G, Previato L, Corti C, Bilato C, Belloni M, Ongaro G, Crepaldi G. Baggio G, et al. Beitr Infusionsther. 1988;23:146-51. Beitr Infusionsther. 1988. PMID: 2484770 Clinical Trial. No abstract available.
• Long term effect of LDL apheresis on coronary heart disease.

  Donner MG, Richter WO, Schwandt P. Donner MG, et al. Eur J Med Res. 1997 Jun 16;2(6):270-4. Eur J Med Res. 1997. PMID: 9182655 Clinical Trial.
• Mobilisation of tissue cholesterol by apheresis.

  Thompson GR. Thompson GR. Prog Clin Biol Res. 1990;337:183-7. Prog Clin Biol Res. 1990. PMID: 2191311 Review. No abstract available.
• Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.

  Mabuchi H, Higashikata T, Kawashiri MA. Mabuchi H, et al. Transfus Apher Sci. 2004 Jun;30(3):233-43. doi: 10.1016/j.transci.2004.01.006. Transfus Apher Sci. 2004. PMID: 15172629 Review.